Jithan V. Aukunuru, Ph.D. - Publications

Affiliations: 
2002 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pharmacy, Pharmacology, Ophthalmology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Devara R, Habibuddin M, Aukunuru J. Enhancement Of Dissolution Rate Of Poorly Soluble Drug Itraconazole By Nanosuspension Technology: Its Preparation And Evaluation Studies Asian Journal of Pharmaceutical and Clinical Research. 11: 414-421. DOI: 10.22159/Ajpcr.2018.V11I4.19933  0.377
2016 Lavanya N, Muzib YI, Aukunuru J, Balekari U. Preparation and evaluation of a novel oral delivery system for low molecular weight heparin. International Journal of Pharmaceutical Investigation. 6: 148-157. PMID 27606258 DOI: 10.4103/2230-973X.187351  0.378
2016 Thadakapally R, Aafreen A, Aukunuru J, Habibuddin M, Jogala S. Preparation and Characterization of PEG-albumin-curcumin Nanoparticles Intended to Treat Breast Cancer. Indian Journal of Pharmaceutical Sciences. 78: 65-72. PMID 27168683 DOI: 10.4103/0250-474X.180250  0.379
2016 Jogala S, Rachamalla SS, Aukunuru J. Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis. Current Drug Delivery. 13: 698-710. PMID 26777886 DOI: 10.2174/1567201813666160114092743  0.421
2015 Jogala S, Rachamalla SS, Aukunuru J. Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin. Journal of Advanced Pharmaceutical Technology & Research. 6: 58-64. PMID 25878975 DOI: 10.4103/2231-4040.154531  0.396
2015 Yerragunta B, Jogala S, Chinnala KM, Aukunuru J. Development of a novel 3-month drug releasing risperidone microspheres. Journal of Pharmacy and Bioallied Sciences. 7: 37-44. PMID 25709335 DOI: 10.4103/0975-7406.148777  0.377
2014 Thadkala K, Nanam PK, Rambabu B, Sailu C, Aukunuru J. Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability. International Journal of Pharmaceutical Investigation. 4: 131-137. PMID 25126526 DOI: 10.4103/2230-973X.138344  0.371
2014 Navitha A, Jogala S, Krishnamohan C, Aukunuru J. Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies. Journal of Advanced Pharmaceutical Technology & Research. 5: 84. PMID 24959417 DOI: 10.4103/2231-4040.133431  0.391
2014 Nanam PK, Thadkala K, Sailu C, Aukunuru J. Investigation of various practical techniques to enhance dissolution of ezetimibe from oral tablets: A comparative study Journal of Young Pharmacists. 6: 8-14. DOI: 10.5530/Jyp.2014.1.2  0.322
2013 Shiny J, Ramchander T, Goverdhan P, Habibuddin M, Aukunuru JV. Development and evaluation of a novel biodegradable sustained release microsphere formulation of paclitaxel intended to treat breast cancer. International Journal of Pharmaceutical Investigation. 3: 119-25. PMID 24167783 DOI: 10.4103/2230-973X.119212  0.341
2013 Bonepally CR, Gandey SJ, Bommineni K, Gottumukkala KM, Aukunuru J. Preparation, Characterisation and In Vivo Evaluation of Silybin Nanoparticles for the Treatment of Liver Fibrosis Tropical Journal of Pharmaceutical Research. 12: 1-6. DOI: 10.4314/Tjpr.V12I1.1  0.392
2010 Anuradha CA, Aukunuru J. Preparation, Characterisation and In vivo Evaluation of Bis-demethoxy Curcumin Analogue (BDMCA) Nanoparticles Tropical Journal of Pharmaceutical Research. 9: 51-58. DOI: 10.4314/Tjpr.V9I1.52036  0.408
2007 Aukunuru J, Bonepally C, Guduri G. Preparation, Characterization and Optimization of Ibuprofen Ointment Intended for Topical and Systemic Delivery Tropical Journal of Pharmaceutical Research. 6: 855-860. DOI: 10.4314/Tjpr.V6I4.14670  0.357
2003 Aukunuru JV, Ayalasomayajula SP, Kompella UB. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells. The Journal of Pharmacy and Pharmacology. 55: 1199-206. PMID 14604462 DOI: 10.1211/0022357021701  0.656
2002 Aukunuru JV, Sunkara G, Ayalasomayajula SP, DeRuiter J, Clark RC, Kompella UB. A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications. Pharmaceutical Research. 19: 278-85. PMID 11934234 DOI: 10.1023/A:1014438800893  0.6
2001 Aukunuru JV, Sunkara G, Bandi N, Thoreson WB, Kompella UB. Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharmaceutical Research. 18: 565-72. PMID 11465409 DOI: 10.1023/A:1011060705599  0.591
2000 Aukunuru JV, Kompella UB, Betageri GV. Simultaneous high performance liquid chromatographic analysis of acetaminophen, salicylamide, phenyltoloxamine, and related products Journal of Liquid Chromatography and Related Technologies. 23: 565-578. DOI: 10.1081/Jlc-100101473  0.491
1999 Kompella UB, Aukunuru JV, Betageri GV. Effect of neutral liposomes on corneal and conjunctival transport of didanosine Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents. 6: 9-14. DOI: 10.1080/107175499267101  0.561
1998 Kompella UB, Katragadda AK, Aukunuru JV, Betageri GV. Effect of liposomal charge on stavudine transport across rabbit cornea and conjunctiva Pharmacy and Pharmacology Communications. 4: 339-343. DOI: 10.1111/J.2042-7158.1998.Tb00708.X  0.55
Show low-probability matches.